Emerging studies suggest Retatru tide , a dual activator targeting both incretin and glucose-dependent insulinotropic polypeptide , could provide a promising development for obesity management . https://getretatrutideaustralia.com/blog/retatrutide-vs-tirzepatide-semaglutide